Ani Pharmaceuticals ANIP
NASDAQ ANIP
$70.70 +0.47 (+0.67%)
As of: Sep 9, 2026 · 3:59 PM EDT

Ani Pharmaceuticals (ANIP) Dividends Paid - Common Growth (3y) (2024 - 2025)

Analysis

Ani Pharmaceuticals (ANIP) Dividends Paid - Common Growth (3y) (2024 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Div. Paid (Common) Growth (3y) (Qtr)
1 Teva Pharmaceutical Industries 42.84 Bn 39.19 Bn 2.15 Bn -
2 Viatris 19.13 Bn 18.24 Bn 1.46 Bn -0.96%
3 Dr Reddys Laboratories 9.91 Bn 9.74 Bn 396.53 Mn -
4 Amneal Pharmaceuticals 5.51 Bn 5.38 Bn 334.51 Mn -
5 Bausch Health Companies 2.30 Bn 464.50 Mn 2.10 Bn -
6 Alvotech 1.50 Bn 1.36 Bn 2.56 Mn -
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn -
8 Amphastar Pharmaceuticals 1.00 Bn 714.13 Mn 93.47 Mn -
9 Fennec Pharmaceuticals 402.10 Mn 360.85 Mn 17.15 Mn -
10 RedHill Biopharma 178.35 Mn 178.35 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 -5.37%
Jun 30, 2025 0.00%
Mar 31, 2025 0.08%
Dec 31, 2024 28.80%